(Q47994663)

7 February 2018

review article

1 reference

title

Antiparkinsonian actions of glutamate antagonists--alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms (English)

1 reference

7 February 2018

author name string

Starr MS

series ordinal

1

1 reference

7 February 2018

publication date

1 January 1995

1 reference

7 February 2018

Journal of neural transmission. Parkinson's disease and dementia section

published in

1 reference

7 February 2018

volume

10

1 reference

7 February 2018

issue

2-3

1 reference

7 February 2018

page(s)

141-185

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1007/bf02251229

exact match

0 references

cites work

Glutamate receptors in the substantia nigra of Parkinson's disease brains.

1 reference

https://api.crossref.org/works/10.1007%2FBF02251229

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02251229

Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02251229

Effects of subacute repeated injections of phencyclidine and MK-801 on substance P content in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02251229

Potentiation by amantadine hydrochloride of L-dopa-induced effects in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02251229

21 January 2018

Identifiers

DOI

10.1007/BF02251229

1 reference

7 February 2018

1 reference

7 February 2018